{
    "2018-03-12": [
        [
            {
                "time": "2018-03-15",
                "original_text": "East Bay company's stock plummets 81% as drug for cystic fibrosis patients fails",
                "features": {
                    "keywords": [
                        "plummets",
                        "drug",
                        "cystic fibrosis",
                        "fails"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-03-15",
                "original_text": "Noteworthy Monday Option Activity: LLY, SWKS, HCA",
                "features": {
                    "keywords": [
                        "Option Activity",
                        "LLY",
                        "SWKS",
                        "HCA"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "technology",
                        "hospitality"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-15",
                "original_text": "The Zacks Analyst Blog Highlights: Coca-Cola, Eli Lilly, Occidental Petroleum, Ross Stores and Wynn Resorts",
                "features": {
                    "keywords": [
                        "Zacks Analyst Blog",
                        "Coca-Cola",
                        "Eli Lilly",
                        "Occidental Petroleum",
                        "Ross Stores",
                        "Wynn Resorts"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "consumer goods",
                        "healthcare",
                        "energy",
                        "retail",
                        "hospitality"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-15",
                "original_text": "What Were AstraZenecaâ€™s Growth Platforms in 4Q17?",
                "features": {
                    "keywords": [
                        "AstraZeneca",
                        "Growth Platforms",
                        "4Q17"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}